Paul Atkinson and Sally Sheard say the decision reflects a cautious and evidence-based approach that protects patients and public funds
Read More Details
Finally We wish PressBee provided you with enough information of ( The real reason two ‘miracle’ Alzheimer’s drugs were rejected for NHS use )
Also on site :